TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$ July 5, 1991
TCL Archive Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center January 29, 1988
